Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study

Background People living with HIV have an increased risk of left ventricular diastolic dysfunction (LVDD) and heart failure. HIV‐associated LVDD may reflect both cardiomyocyte and systemic metabolic derangements, but the underlying pathways remain unclear. Methods and Results To explore such pathway...

Full description

Bibliographic Details
Main Authors: Claudio A. Bravo, Simin Hua, Amy Deik, Jason Lazar, David B. Hanna, Justin Scott, Jin Choul Chai, Robert C. Kaplan, Kathryn Anastos, Octavio A. Robles, Clary B. Clish, Jorge R. Kizer, Qibin Qi
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.013522
_version_ 1827992580596432896
author Claudio A. Bravo
Simin Hua
Amy Deik
Jason Lazar
David B. Hanna
Justin Scott
Jin Choul Chai
Robert C. Kaplan
Kathryn Anastos
Octavio A. Robles
Clary B. Clish
Jorge R. Kizer
Qibin Qi
author_facet Claudio A. Bravo
Simin Hua
Amy Deik
Jason Lazar
David B. Hanna
Justin Scott
Jin Choul Chai
Robert C. Kaplan
Kathryn Anastos
Octavio A. Robles
Clary B. Clish
Jorge R. Kizer
Qibin Qi
author_sort Claudio A. Bravo
collection DOAJ
description Background People living with HIV have an increased risk of left ventricular diastolic dysfunction (LVDD) and heart failure. HIV‐associated LVDD may reflect both cardiomyocyte and systemic metabolic derangements, but the underlying pathways remain unclear. Methods and Results To explore such pathways, we conducted a pilot study in the Bronx and Brooklyn sites of the WIHS (Women's Interagency HIV Study) who participated in concurrent, but separate, metabolomics and echocardiographic ancillary studies. Liquid chromatography tandem mass spectrometry–based metabolomic profiling was performed on plasma samples from 125 HIV‐infected (43 with LVDD) and 35 HIV‐uninfected women (9 with LVDD). Partial least squares discriminant analysis identified polar metabolites and lipids in the glycerophospholipid‐metabolism and fatty‐acid‐oxidation pathways associated with LVDD. After multivariable adjustment, LVDD was significantly associated with higher concentrations of diacylglycerol 30:0 (odds ratio [OR], 1.60, 95% CI [1.01–2.55]); triacylglycerols 46:0 (OR 1.60 [1.04–2.48]), 48:0 (OR 1.63 [1.04–2.54]), 48:1 (OR 1.62 [1.01–2.60]), and 50:0 (OR 1.61 [1.02–2.53]); acylcarnitine C7 (OR 1.88 [1.21–2.92]), C9 (OR 1.99 [1.27–3.13]), and C16 (OR 1.80 [1.13–2.87]); as well as lower concentrations of phosphocholine (OR 0.59 [0.38–0.91]). There was no evidence of effect modification of these relationships by HIV status. Conclusions In this pilot study, women with or at risk of HIV with LVDD showed alterations in plasma metabolites in the glycerophospholipid‐metabolism and fatty‐acid‐oxidation pathways. Although these findings require replication, they suggest that improved understanding of metabolic perturbations and their potential modification could offer new approaches to prevent cardiac dysfunction in this high‐risk group.
first_indexed 2024-04-10T04:06:18Z
format Article
id doaj.art-d70f232d2d9c4143a18ec1e3f93e9d29
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-10T04:06:18Z
publishDate 2020-02-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-d70f232d2d9c4143a18ec1e3f93e9d292023-03-13T05:25:33ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802020-02-019410.1161/JAHA.119.013522Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV StudyClaudio A. Bravo0Simin Hua1Amy Deik2Jason Lazar3David B. Hanna4Justin Scott5Jin Choul Chai6Robert C. Kaplan7Kathryn Anastos8Octavio A. Robles9Clary B. Clish10Jorge R. Kizer11Qibin Qi12Division of Cardiology Department of Medicine Columbia University Medical Center New York NYDepartment of Epidemiology & Population Health Albert Einstein College of Medicine Bronx NYMetabolomics Platform Broad Institute of MIT and Harvard Cambridge MADivision of Cardiovascular Medicine State University of New York Downstate Medical Center Brooklyn NYDepartment of Epidemiology & Population Health Albert Einstein College of Medicine Bronx NYMetabolomics Platform Broad Institute of MIT and Harvard Cambridge MADepartment of Epidemiology & Population Health Albert Einstein College of Medicine Bronx NYDepartment of Epidemiology & Population Health Albert Einstein College of Medicine Bronx NYDepartment of Epidemiology & Population Health Albert Einstein College of Medicine Bronx NYDepartment of Biologic Sciences Universidad de Chile Santiago ChileMetabolomics Platform Broad Institute of MIT and Harvard Cambridge MADivision of Cardiology San Francisco Veterans Affairs Health Care System University of California San Francisco San Francisco CADepartment of Epidemiology & Population Health Albert Einstein College of Medicine Bronx NYBackground People living with HIV have an increased risk of left ventricular diastolic dysfunction (LVDD) and heart failure. HIV‐associated LVDD may reflect both cardiomyocyte and systemic metabolic derangements, but the underlying pathways remain unclear. Methods and Results To explore such pathways, we conducted a pilot study in the Bronx and Brooklyn sites of the WIHS (Women's Interagency HIV Study) who participated in concurrent, but separate, metabolomics and echocardiographic ancillary studies. Liquid chromatography tandem mass spectrometry–based metabolomic profiling was performed on plasma samples from 125 HIV‐infected (43 with LVDD) and 35 HIV‐uninfected women (9 with LVDD). Partial least squares discriminant analysis identified polar metabolites and lipids in the glycerophospholipid‐metabolism and fatty‐acid‐oxidation pathways associated with LVDD. After multivariable adjustment, LVDD was significantly associated with higher concentrations of diacylglycerol 30:0 (odds ratio [OR], 1.60, 95% CI [1.01–2.55]); triacylglycerols 46:0 (OR 1.60 [1.04–2.48]), 48:0 (OR 1.63 [1.04–2.54]), 48:1 (OR 1.62 [1.01–2.60]), and 50:0 (OR 1.61 [1.02–2.53]); acylcarnitine C7 (OR 1.88 [1.21–2.92]), C9 (OR 1.99 [1.27–3.13]), and C16 (OR 1.80 [1.13–2.87]); as well as lower concentrations of phosphocholine (OR 0.59 [0.38–0.91]). There was no evidence of effect modification of these relationships by HIV status. Conclusions In this pilot study, women with or at risk of HIV with LVDD showed alterations in plasma metabolites in the glycerophospholipid‐metabolism and fatty‐acid‐oxidation pathways. Although these findings require replication, they suggest that improved understanding of metabolic perturbations and their potential modification could offer new approaches to prevent cardiac dysfunction in this high‐risk group.https://www.ahajournals.org/doi/10.1161/JAHA.119.013522heart failureHIVleft ventricular diastolic dysfunctionmetabolomics
spellingShingle Claudio A. Bravo
Simin Hua
Amy Deik
Jason Lazar
David B. Hanna
Justin Scott
Jin Choul Chai
Robert C. Kaplan
Kathryn Anastos
Octavio A. Robles
Clary B. Clish
Jorge R. Kizer
Qibin Qi
Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
heart failure
HIV
left ventricular diastolic dysfunction
metabolomics
title Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study
title_full Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study
title_fullStr Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study
title_full_unstemmed Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study
title_short Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study
title_sort metabolomic profiling of left ventricular diastolic dysfunction in women with or at risk for hiv infection the women s interagency hiv study
topic heart failure
HIV
left ventricular diastolic dysfunction
metabolomics
url https://www.ahajournals.org/doi/10.1161/JAHA.119.013522
work_keys_str_mv AT claudioabravo metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT siminhua metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT amydeik metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT jasonlazar metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT davidbhanna metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT justinscott metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT jinchoulchai metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT robertckaplan metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT kathrynanastos metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT octavioarobles metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT clarybclish metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT jorgerkizer metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy
AT qibinqi metabolomicprofilingofleftventriculardiastolicdysfunctioninwomenwithoratriskforhivinfectionthewomensinteragencyhivstudy